Fujian Wanchen Biotechnology Group Co.,Ltd. (SHE:300972)

SHE:300972 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	3,436	2,381	1,210	115.04	216.21	33.54
Trading Asset Securities	0.01	-	-	-	20.03	-
Cash & Short-Term Investments	3,436	2,381	1,210	115.04	236.24	33.54
Cash Growth	62.78%	96.80%	951.57%	-51.30%	604.37%	23.52%
Accounts Receivable	10.36	19.42	27.17	14.59	9.57	2.37
Other Receivables	56.72	66.05	122.87	4.61	0.57	0.3
Receivables	67.09	85.47	150.05	19.2	10.13	2.67
Inventory	1,672	2,141	733.29	100.11	55.37	50.8
Prepaid Expenses	-	-	-	1.48	-	-
Other Current Assets	894.88	1,163	256.2	42.87	0.64	6.12
Total Current Assets	6,070	5,771	2,349	278.69	302.39	93.13
Property, Plant & Equipment	1,169	1,271	1,371	796.9	506.33	506.01
Long-Term Investments	-	-	-	0.24	-	-
Other Intangible Assets	82.17	59.52	60.59	53.04	53.41	54.82
Long-Term Accounts Receivable	-	3.02	0.73	0.12	-	-
Long-Term Deferred Tax Assets	88.22	95.12	74.64	11.9	-	-
Long-Term Deferred Charges	35.88	37.5	51.2	4.9	-	-
Other Long-Term Assets	15.34	16.79	18.07	55.35	1.05	4.31
Total Assets	7,460	7,253	3,925	1,201	863.18	658.27
Accounts Payable	1,533	2,094	943.17	117.38	59.68	39.47
Accrued Expenses	114.73	301.32	115.67	27.06	13.18	12.4
Short-Term Debt	884.88	956.01	510.77	148.37	64.78	88.06
Current Portion of Long-Term Debt	-	12.67	9.28	6.54	30.04	61.39
Current Portion of Leases	-	155	146.03	16.17	0.08	-
Current Income Taxes Payable	272.14	208.09	54.68	0.01	5.61	-
Current Unearned Revenue	262.35	312.17	169.71	8.93	1.17	4.21
Other Current Liabilities	1,351	1,089	690.9	7.03	6	6.92
Total Current Liabilities	4,419	5,128	2,640	331.49	180.54	212.46
Long-Term Debt	366.44	237.48	148.35	110.5	-	30
Long-Term Leases	240.89	299.21	324.81	31.24	0.17	-
Long-Term Unearned Revenue	34	36.12	40.45	43.62	29.77	15.16
Long-Term Deferred Tax Liabilities	83.76	91.17	75.72	11.93	-	-
Total Liabilities	5,144	5,792	3,230	528.79	210.47	257.61
Common Stock	187.62	179.99	154.69	153.5	153.5	115.13
Additional Paid-In Capital	650.86	534.07	364.09	305.15	303.67	113.44
Retained Earnings	783.67	384.1	126.58	209.5	195.54	172.09
Total Common Equity	1,622	1,098	645.36	668.15	652.71	400.65
Minority Interest	694.33	363.19	50.45	4.21	-	-
Shareholders' Equity	2,316	1,461	695.81	672.36	652.71	400.65
Total Liabilities & Equity	7,460	7,253	3,925	1,201	863.18	658.27
Total Debt	1,492	1,660	1,139	312.82	95.07	179.44
Net Cash (Debt)	1,944	720.24	70.45	-197.78	141.18	-145.9
Net Cash Growth	152.64%	922.33%	-	-	-	-
Net Cash Per Share	9.89	3.85	0.46	-1.27	1.00	-1.27
Filing Date Shares Outstanding	179.99	179.99	172.39	153.5	153.5	115.13
Total Common Shares Outstanding	179.99	179.99	154.69	153.5	153.5	115.13
Working Capital	1,651	642.52	-290.99	-52.8	121.85	-119.33
Book Value Per Share	9.01	6.10	4.17	4.35	4.25	3.48
Tangible Book Value	1,540	1,039	584.77	615.11	599.3	345.84
Tangible Book Value Per Share	8.56	5.77	3.78	4.01	3.90	3.00
Buildings	-	616.41	613.66	370.04	368.64	365.76
Machinery	-	734.41	698.29	446.97	433.87	418.33
Construction In Progress	-	1.1	1.24	302.84	35.05	3.36

Source: S&P Global Market Intelligence. Standard template. Financial Sources.